drugset
drugset / Trial / NCT00038701

Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas

NCT00038701 ↗

Phase 2 Terminated 6 enrolled M.D. Anderson Cancer Center
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The goal is to assess survival and patterns of failure in patients treated with Gemzar-based chemoradiation and TNP-470 for locally advanced adenocarcinoma of the pancreas.

Timeline

Start
1999-08
Primary completion
2004-05-11
Completion
2004-05-11

Outcome

Outcome not reported

Stopped (Enrollment): “Slow accrual.”

Drugs

EvaluationDrugModalityDoseRoute
Subject O-CHLOROACETYLCARBAMOYLFUMAGILLOL Small molecule — —

Indications

pancreatic neoplasm